Associations between immunologic, inflammatory, and oxidative stress markers with severity of depressive symptoms: An analysis of the 2005-2006 National Health and Nutrition Examination Survey

NeuroToxicology

Volumn 31, Issue 1, 2010, Pages 126-133

  Kobrosly, Roni ^a   van Wijngaarden, Edwin ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Depression; Epidemiology; Inflammation; Oxidative stress

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; EDUCATIONAL STATUS; FEMALE; HEALTH SURVEY; HUMAN; INCOME; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PATIENT HEALTH QUESTIONNAIRE; PHYSICAL ACTIVITY; POVERTY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SCORING SYSTEM; SMOKING; THROMBOCYTE COUNT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DEPRESSIVE DISORDER; FEMALE; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; LOGISTIC MODELS; MALE; MIDDLE AGED; NUTRITION SURVEYS; OXIDATIVE STRESS; PLATELET COUNT; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 74249103565     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2009.10.005     Document Type: Article

References (61)

1. Abramson J.L., Hooper W.C., Jones D.P., Ashfaq S., Rhodes S.D., Weintraub W.S., et al. Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis 178 (2005) 115-121
2. Almeida O.P., Norman P., Hankey G.J., Jamrozik K., and Flicker L. The association between C-reactive protein concentration and depression in later life is due to poor physical health: results from the Health in Men Study (HIMS). Psychol Med 37 (2007) 1775-1786
3. Arbelaez J.J., Ariyo A.A., Crum R.M., Fried L.P., and Ford D.E. Depressive symptoms, inflammation, and ischemic stroke in older adults: a prospective analysis in the cardiovascular health study. J Am Geriatr Soc 55 November (11) (2007) 1825-1830
4. Berry W.D., and Feldman S. Multiple regression in practice (1985), Sage Publications Inc., Thousand Oaks, CA
5. Boscarino J.A., and Chang J. Higher abnormal leukocyte and lymphocyte counts 20 years after exposure to severe stress: research and clinical implications. Psychosom Med 61 (1999) 378-386
6. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data (2009), U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Hyattsville, MD
7. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire (or examination protocol, or laboratory protocol) (2009), U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Hyattsville, MD
8. Chapple I.L.C., Milward M.R., and Dietrich T. The prevalence of inflammatory periodontitis is negatively associated with serum antioxidant concentrations. J Nutr 137 (2007) 657-664
9. Cheng M.L., Chen C.M., Gu P.W., Ho H.Y., and Chiu D.T. Elevated levels of myeloperoxidase, white blood cell count and 3-chlorotyrosine in Taiwanese patients with acute myocardial infarction. Clin Biochem 41 (2008) 554-560
10. Clarke D.D., and Sokoloff L. Circulation and energy metabolism of the brain. In: Siegel G.J., Agranoff B.W., Albers R.W., Fisher S.K., and Uhler M.D. (Eds). Basic neurochemistry: molecular, cellular, and medical aspects (1998), Lippincott-Raven, Philadelphia 637-639
11. Costanzo A., Moretti F., Burgio V.L., Bravi C., Guido F., Levrero M., et al. Endothelial activation by angiotensin II through NF-kappaB and p38 pathways: involvement of NF-kappaB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin. J Cell Physiol 195 (2003) 402-410
12. Cyranowski J.M., Marsland A.L., Bromberger J.T., Whiteside T.L., Chang Y., and Matthews K.A. Depressive symptoms and production of proinflammatory cytokines by peripheral blood mononuclear cells stimulated in vitro. Brain Behav Immun 21 2 (2007) 229-237
13. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., and Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9 1 (2008) 46-56
14. Darko D.F., Gillin J.C., Risch S.C., Bulloch K., Golshan S., Tasevska Z., et al. Immune cells and the hypothalamic-pituitary axis in major depression. Psychiatry Res 25 (1988) 173-179
15. Darko D.F., Rose J., Gillin J.C., Golshan S., and Baird S.M. Neutrophilia and lymphopenia in major mood disorders. Psychiatry Res 25 (1998) 243-251
16. Dumont P., Andreoli A., Borgacci S., Carballeira Y., Rentsch D., de Tonnac N., et al. Quick detection of depression: a significant clinical issue. Rev Med Suisse 1 5 (2005) 344-346
17. Ford D.E., and Erlinger T.P. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 164 9 (2004) 1010-1014
18. Ford D.E., Mead L.A., Chang P.P., Cooper-Patrick L., Wang N.Y., and Klag M. Depression is a risk factor for coronary artery disease in men: the Precursors Study. Arch Intern Med 158 (1998) 1422-1426
19. Gilman S.E., Kawachi I., and Fitzmaurice G.M. Socioeconomic status in childhood and the lifetime risk of major depression. Int J Epidemiol 31 2 (2002) 359-367
20. Graeff F.G., Guimarães F.S., De Andrade T.G., and Deakin J.F. Role of 5HT in stress, anxiety and depression. Pharm Biochem Behav 54 (1998) 129-141
21. Hamer M., Molloy G.J., de Oliveira C., and Demakakos P. Persistent depressive symptomatology and inflammation: To what extent do health behaviours and weight control mediate this relationship?. Brain Behav Immun 23 4 (2009) 413-418
22. Herbert T.B., and Cohen S. Depression and immunity: a meta-analytic review. Psychol Bull 113 (1993) 472-486
23. Hibbeln J.R., and Salem N. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr 62 (1995) 1-9
24. Howren M.B., Lamkin D.M., and Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71 (2009) 171-186
25. Janszky I., Lekander M., Blom M., Georgiades A., and Ahnve S. Self-rated health and vital exhaustion, but not depression, is related to inflammation in women with coronary heart disease. Brain Behav Immun 19 (2005) 555-563
26. Joyce P.R., Hawes C.R., Mulder R.T., Sellman J.D., Wilson D.A., and Boswell D.R. Elevated levels of acute phase proteins in major depression. Biol Psychiatry 32 (1992) 1035-1041
27. Kessler R., Berglund P., Delmer O., Jin R., Merikangas K.R., and Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62 (2005) 593-602
28. Kop W.J., Gottdiener J.S., and Tangen C.M. Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol 89 4 (2002) 419-424
29. Kroenke K., and Spitzer R.L. The PHQ-9: a new depression and diagnostic severity measure. Psychiatr Ann 32 (2002) 509-521
30. Kroenke K., Spitzer R.L., and Williams J.B.W. The PHQ-9. Validity of a brief depression severity measure. J Gen Intern Med 16 (2001) 606-613
31. Kronfol Z., Silva J., Greden J., Dembinski S., Gardner R., and Carroll B. Impaired lymphocyte function in depressive illness. Life Sci 33 (1983) 241-247
32. Kronfol Z., Turner R., Nasrallah H., and Winokur G. Leukocyte regulation in depression and schizophrenia. Psychiatry Res 13 (1984) 13-18
33. Lee D.H., Lim J.S., Song K., Boo Y., and Jacobs Jr. D.R. Graded associations of blood lead and urinary cadmium concentrations with oxidative-stress-related markers in the U.S. population: results from the Third National Health and Nutrition Examination Survey. Environ Health Perspect 114 3 (2006) 350-354
34. Maes M. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuroendocrinol Lett 29 3 (2008) 287-291
35. Maes M., Van der Planken M., Stevens W.J., Peeters D., DeClerck L.S., Bridts C.H., et al. Leukocytosis, monocytosis and neutrophilia: hallmarks of severe depression. J Psychiatr Res 26 2 (1992) 125-134
36. Maes M., Meltzer H.Y., Stevens W., Calabrese J., and Cosyns P. Natural killer cell activity in major depression: relation to circulating natural killer cells, cellular indices of the immune response, and depressive phenomenology. Prog Neuropsychopharmacol Biol Psychiatry 18 (1994) 717-730
37. Maes M., Mihaylova I., and Leunis J.C. Increased serum IgM antibodies directed against phosphatidyl inositol (PI) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against PI is one factor underpinning the comorbidity between both CFS and depression. Neuroendocrinol Lett 28 (2007) 861-867
38. Maes M., Yirmyia R., Noraberg J., Brene S., Hibbeln J., Perini G., et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 24 1 (2009) 27-53
39. Martin A., Rief W., and Klaiberg A. Validity of the Brief Patient Health Questionnaire Mood Scale (PHQ-9) in the general population. Gen Hosp Psychiatry 28 (2006) 71-77
40. Maxwell S.R., Dietrich T., and Chapple I.L.C. Prediction of serum total antioxidant activity from the concentration of individual serum antioxidants. Clin Chim Acta 372 (2006) 188-194
41. Maziere C., Auclair M., and Maziere J.C. Tumor necrosis factor enhances low density lipoprotein oxidative modification by monocytes and endothelial cells. FEBS Lett 338 (1994) 43-46
42. McAdams C., and Leonard B.E. Neutrophil and monocyte phagocytosis in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 17 (1993) 971-984
43. Michel T.M., Frangou S., Thiemeyer D., Camara S., Jecel J., Nara K., et al. Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder-a postmortem study. Psychiatry Res 151 (2007) 145-150
44. Miller N.J., Rice-Evans C., Davies M.J., Gopinathan V., and Milner A. A novel method for measuring antioxidant capacity and its application to measuring the anti-oxidant status in premature neonates. Clin Sci 84 (1993) 407-412
45. Mogensen T.H., Melchjorsen J., Hollsberg P., and Paludan S.R. Activation of NF-kappaB in virus-infected macrophages is dependent on mitochondrial oxidative stress and intracellular calcium: downstream involvement of the kinases TGF-beta-activated kinase 1, mitogen activated kinase/extracellular signal-regulated kinase kinase 1, and I kappaB kinase. J Immunol 170 (2003) 6224-6233
46. Müller N., Schwarz M.J., Dehning S., Douhe A., Cerovecki A., Goldstein-Müller B., et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 11 7 (2006) 680-684
47. Nazmi A., and Victora C.G. Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies. BMC Public Health 17 (2007) 212
48. Pfäfflin A., and Schleicher E. Inflammation markers in point-of-care testing (POCT). Anal Bioanal Chem 393 5 (2009) 1473-1480
49. Ranjit N., Diez-Roux A.V., Shea S., Cushman M., Ni H., and Seeman T. Socioeconomic position, race/ethnicity, and inflammation in the multi-ethnic study of atherosclerosis. Circulation 116 21 (2007) 2383-2390
50. Rothermundt M., Arolt V., Peters M., Gutbrodt H., Fenker J., Kersting A., et al. Inflammatory markers in major depression and melancholia. J Affect Disord 63 (2001) 93-102
51. Rugulies R. Depression as a predictor for coronary heart disease: a review and meta-analysis. Am J Prev Med 23 (2002) 51-61
52. Sarandol A., Sarandol E., Eker S.S., Erdinc S., Vatansever E., and Kirli S. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol Clin Exp 22 (2007) 67-73
53. Scott S.C., Goldberg M.S., and Mayo N.E. Statistical assessment of ordinal outcomes in comparative studies. J Clin Epidemiol 50 1 (1997) 45-55
54. Singer E.A., Palapattu G.S., and van Wijngaarden E. Prostate-specific antigen levels in relation to consumption of nonsteroidal anti-inflammatory drugs and acetaminophen; results from the 2001-2002 National Health and Nutrition Examination Survey. Cancer 113 8 (2008) 2053-2057
55. Tiemeier H., Hofman A., van Tuijl H.R., Kiliaan A.J., Meijer J., and Breteler M.M. Inflammatory proteins and depression in the elderly. Epidemiology 14 1 (2003) 103-107
56. Weizman R., Laor N., Podliszewski E., Notti I., Djaldetti M., and Bessler H. Cytokine production in major depressed patients before and after clomipramine treatment. Biol Psychiatry 35 (1994) 42-47
57. Wichers M.C., and Maes M. The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression. J Psychiatry Neurosci 29 1 (2004) 11-17
58. Wulsin L., Somoza E., and Heck J. The feasibility of using the Spanish PHQ-9 to screen for depression in primary care in Honduras. Prim Care Companion J Clin Psychiatry 4 5 (2002) 191-195
59. Yeung A., Fung F., Yu S.C., Vorono S., Ly M., Wu S., et al. Validation of the Patient Health Questionnaire-9 for depression screening among Chinese Americans. Compr Psychiatry 49 2 (2008) 211-217
60. Zhang L., Zalewski A., Liu Y., Mazurek T., Cowan S., Martin J.L., et al. Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation 108 (2003) 472-478
61. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 15 (2001) 199-226